CTSL3P

Model summary

A soluble cysteine protease that is synthesized as an auto-inhibited zymogen and activated in acidic compartments to perform limited proteolysis. It operates primarily within lysosomes, where regulated activation enables precise cleavage of protein substrates that support antigen handling and extracellular matrix turnover. The enzyme’s inhibitory propeptide ensures latency during trafficking, and its papain-like catalytic core executes endopeptidic reactions once matured. While its principal residence is intracellular organelles, transient soluble pools can appear outside the lysosome during trafficking or stress.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminus (residues 1–33) carries IPR013201, the cathepsin propeptide inhibitor domain (I29). This prosegment folds back onto the catalytic cleft and blocks activity in zymogen form, a hallmark of papain-like proteases. The entire polypeptide (residues 1–101) is encompassed by IPR038765, the papain-like cysteine peptidase superfamily, establishing a thiol-dependent protease fold. From residues 13–100, IPR013128 assigns the protein to the Peptidase C1A family, which includes lysosomal cathepsins. The ordered layout—an N-terminal auto-inhibitory I29 propeptide followed by a papain-like catalytic core—causes thiol protease chemistry upon removal of the prosegment. This architecture dictates a cysteine protease mechanism that requires precise protein–protein contacts both for inhibition and for substrate/adaptor recognition, supporting GO:0005515 protein binding as a core molecular function.

2. 02

   From this fold and family assignment, the molecular function resolves into cysteine-type endopeptidase activity that executes limited proteolysis rather than bulk degradation.

   The I29 domain ensures latency during biosynthesis and trafficking; activation occurs in acidic compartments where the papain-like core is stabilized. This enzymatic profile directly drives GO:0006508 proteolysis: the enzyme performs endopeptidic cleavages that remodel protein substrates and generate peptide products.

3. 03

   Cellular localization follows from the same logic.

   The I29-bearing C1A proteases are classically sorted to lysosomes, where acidic pH triggers maturation and activity. The soluble, non-membranous architecture and lysosomal targeting signals of this family point to a luminal lysosomal residency, consistent with a secretory-pathway zymogen that matures in endo-lysosomal compartments. While the dominant steady-state location is intracellular organelles, transient pools can appear in cytosolic and nucleoplasmic fractions during stress, trafficking, or leakage, aligning with GO:0005829 cytosol and GO:0005654 nucleoplasm as minor or conditional locales. The functional core, however, anchors the inference of a lysosomal soluble enzyme.

4. 04

   Mechanistically, the I29 propeptide binds and occludes the active-site cleft; acidic maturation pathways and proteolytic trimming release inhibition, yielding an active cysteine protease that cleaves target proteins.

   This activity supports antigen processing and extracellular matrix remodeling in contexts where the enzyme is secreted or pericellular. The reliance on regulated activation and complex formation explains robust protein binding behavior and suggests specific interaction partners. I hypothesize that trafficking receptors and sorting machinery (such as mannose-6-phosphate receptors and mannose-6-phosphate receptors) chaperone the zymogen to lysosomes; luminal activators and inhibitors (e.g., legumain/asparaginyl endopeptidase and cystatin family members) tune activity; and endogenous receptors like NTRAIL/LAMP9 transiently bind the protease during maturation. Together, these interactions position the enzyme as a soluble lysosomal cysteine protease that executes tightly controlled proteolysis with ancillary roles in antigen handling and matrix turnover.